Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.
Issue Date
2021-04-19Keywords
SLC1A5SLC3A2
SLC7A5
anti-tumor immunity
immunometabolism
Natural Killer cells
nutrient transporters
tumor microenvironment
Metadata
Show full item recordJournal
Frontiers in immunologyDOI
10.3389/fimmu.2021.624324PubMed ID
33953707Item Type
ArticleLanguage
enEISSN
1664-3224ae974a485f413a2113503eed53cd6c53
10.3389/fimmu.2021.624324
Scopus Count
Collections
Related articles
- The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).
- Authors: Cormerais Y, Massard PA, Vucetic M, Giuliano S, Tambutté E, Durivault J, Vial V, Endou H, Wempe MF, Parks SK, Pouyssegur J
- Issue date: 2018 Feb 23
- Amino acids regulate mTOR pathway and milk protein synthesis in a mouse mammary epithelial cell line is partly mediated by T1R1/T1R3.
- Authors: Wang Y, Liu J, Wu H, Fang X, Chen H, Zhang C
- Issue date: 2017 Dec
- Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer.
- Authors: Alfarsi LH, El-Ansari R, Craze ML, Masisi BK, Mohammed OJ, Ellis IO, Rakha EA, Green AR
- Issue date: 2020 Feb 19
- Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth.
- Authors: Bothwell PJ, Kron CD, Wittke EF, Czerniak BN, Bode BP
- Issue date: 2018 Jul 19
- Enhanced glutamine uptake influences composition of immune cell infiltrates in breast cancer.
- Authors: Ansari RE, Craze ML, Althobiti M, Alfarsi L, Ellis IO, Rakha EA, Green AR
- Issue date: 2020 Jan